A levee broke around noon in Tukwila prompting the National Weather Service to issue a flash flood warning. Folks have been under a Go-Now alert since the weekend. Political malpractice: Johnson faces ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion Pharmaceuticals currently has the industry's largest AI supercomputer. It also has partnerships with major drugmakers, but these have yet to yield major wins. Recursion'a lack of clinical ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...

The Writers Guild of America East is telling its CBS News members that the network assured them that they won’t face discipline if they decline to respond to new editor-in-chief Bari Weiss’ memo to ...

“I hope you are as excited as I am about the prospect of elevating CBS News to its rightful place as No. 1: the most trusted and most consumed news source in the nation,” Weiss wrote. “So, I’m ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. It's common for clinical-stage biotech companies to post net ...

Last week, the Department of Homeland Security debuted a recruitment strategy to expand the ranks of ICE: sign-on bonuses. Thanks to a rush of cash from the One Big Beautiful Bill Act, the department ...